store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ziresovir (RO-0529) 是一种呼吸道合胞病毒融合蛋白 (RSV F) 抑制剂,抑制 RSV 活性,可用于研究合胞病毒感。
产品描述 | Ziresovir (RO-0529) is a respiratory syncytial virus fusion protein (RSV F) inhibitor that inhibits RSV activity and can be used in the study of syncytial virus sensing. |
靶点活性 | RSV F:3 nM (EC50) |
体外活性 | With EC50/EC90 values (μM) of 0.003/0.005 (WT), 2.1/10.0 (D486N), and >10/>10 (D489A), Ziresovir exhibits different efficacy in Wild Type (WT) and Mutant Strains RSV, respectively[1].Inhibiting the RSV F protein-induced cell–cell fusion process, RO-0529 (100 nM; 4 d) suppresses the syncytia formation induced by the RSV F protein[1]. |
体内活性 |
Ziresovir (12.5 mg/kg, 50 mg/kg; p.o.; twice daily; 4 d) leads to a reduction of RSV titer in the mouse lung[1]. With a single dose of 10 mg/kg administered orally, Ziresovir exhibits good oral exposure and bioavailability, with an F(%) of 32% in male Wistar-Han rats[1]. Following a single oral dose of 150 mg/kg, Ziresovir demonstrates higher tissue distribution to the lung than plasma in CD-1 mice[1]. |
别名 | AK0529, RO-0529 |
分子量 | 439.53 |
分子式 | C22H25N5O3S |
CAS No. | 1422500-60-4 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (227.52 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2752 mL | 11.3758 mL | 22.7516 mL | 56.8789 mL |
5 mM | 0.455 mL | 2.2752 mL | 4.5503 mL | 11.3758 mL | |
10 mM | 0.2275 mL | 1.1376 mL | 2.2752 mL | 5.6879 mL | |
20 mM | 0.1138 mL | 0.5688 mL | 1.1376 mL | 2.8439 mL | |
50 mM | 0.0455 mL | 0.2275 mL | 0.455 mL | 1.1376 mL | |
100 mM | 0.0228 mL | 0.1138 mL | 0.2275 mL | 0.5688 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ziresovir 1422500-60-4 Microbiology/Virology RSV RO 0529 RO0529 AK0529 AK-0529 RO-0529 AK 0529 Inhibitor inhibitor inhibit